Procept Biorobotics Share Price (NASDAQ: PRCT)

$40.2

▲

-0.14

(-0.35%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Procept Biorobotics Stock chart to analyse performance

Procept Biorobotics stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$40.00
Today's High:$40.60
$40.20
0.5%
Downside
Day's Volatility :1.48%
Upside
0.99%
52 Weeks Low:$37.12
52 Weeks High:$103.81
$40.20
7.66%
Downside
52 Weeks Volatility :64.24%
Upside
61.28%

Procept Biorobotics Stock Returns

Period	Procept Biorobotics	Sector (Health Care)	Index (Russel 2000)
3 Months	-30.65%	3.6%	0.0%
6 Months	-33.7%	-7.7%	0.0%
1 Year	-49.14%	-12.6%	0.0%
3 Years	-0.74%	9.5%	-4.7%

Procept Biorobotics Key Stats

Check Procept Biorobotics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$40.34
Open	$40.5
Today's High	$40.6
Today's Low	$40.0
Market Capitalization	$2.3B
Today's Volume	$769.2K
52 Week High	$103.8099
52 Week Low	$37.12
Revenue TTM	$275.0M
EBITDA	$-85.9M
Earnings Per Share (EPS)	$-1.54
Profit Margin	-30.6%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-26.4%

Stock Returns calculator for Procept Biorobotics Stock including INR - Dollar returns

The Procept Biorobotics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Procept Biorobotics investment value today

Current value as on today

₹56,170

Returns

₹43,830

(-43.83%)

Returns from Procept Biorobotics Stock

₹49,114 (-49.11%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Procept Biorobotics Stock

26%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Search interest for Procept Biorobotics Stock from India on INDmoney has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Procept Biorobotics

Name
Holdings %
Name
Holdings %
FMR Inc
14.78%
Vanguard Group Inc
9.43%
BlackRock Inc
6.97%
AllianceBernstein L.P.
3.85%
Westfield Capital Management Company, L.P.
2.87%
T. Rowe Price Investment Management,Inc.
2.75%

Analyst Recommendation on Procept Biorobotics Stock

Rating

Trend

Buy

86%Buy

13%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Procept Biorobotics(by analysts ranked 0 to 5 stars)

Procept Biorobotics Share Price Target

What analysts predicted

Upside of 64.73%

Target:

$66.22

Current:

$40.20

Procept Biorobotics share price target is $66.22, a slight Upside of 64.73% compared to current price of $40.20 as per analysts' prediction.

Procept Biorobotics Stock Insights

Price Movement
In the last 1 month, PRCT stock has moved down by -21.8%
Increasing Revenue
Revenue is up for the last 21 quarters, 1.19M → 79.18M (in $), with an average increase of 17.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -24.73M → -19.57M (in $), with an average increase of 26.4% per quarter
PRCT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 78.1%
PRCT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 160.2%
Price to Sales
ForPRCT every $1 of sales, investors are willing to pay $7.9, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Procept Biorobotics Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$6.2M	-
Net Income	$-42.7M	-
Net Profit Margin	-691.41%	-

	FY20	Y/Y Change
Revenue	$7.7M	↑ 25.09%
Net Income	$-58.3M	↑ 36.58%
Net Profit Margin	-754.89%	↓ 63.48%

	FY21	Y/Y Change
Revenue	$34.5M	↑ 346.72%
Net Income	$-62.4M	↑ 7.09%
Net Profit Margin	-180.96%	↑ 573.93%

	FY22	Y/Y Change
Revenue	$75.0M	↑ 117.6%
Net Income	$-93.6M	↑ 50.01%
Net Profit Margin	-124.76%	↑ 56.2%

	FY23	Y/Y Change
Revenue	$136.2M	↑ 81.55%
Net Income	$-105.9M	↑ 13.16%
Net Profit Margin	-77.76%	↑ 47.0%

	FY24	Y/Y Change
Revenue	$224.5M	↑ 64.84%
Net Income	$-91.4M	↓ 13.68%
Net Profit Margin	-40.72%	↑ 37.04%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$44.5M	↑ 2.2%
Net Income	$-26.0M	↓ 5.62%
Net Profit Margin	-58.28%	↑ 4.83%

	Q2 FY24	Q/Q Change
Revenue	$53.4M	↑ 19.79%
Net Income	$-25.6M	↓ 1.28%
Net Profit Margin	-48.03%	↑ 10.25%

	Q3 FY24	Q/Q Change
Revenue	$58.4M	↑ 9.4%
Net Income	$-21.0M	↓ 18.15%
Net Profit Margin	-35.93%	↑ 12.1%

	Q4 FY24	Q/Q Change
Revenue	$68.2M	↑ 16.9%
Net Income	$-18.9M	↓ 10.1%
Net Profit Margin	-27.63%	↑ 8.3%

	Q1 FY25	Q/Q Change
Revenue	$69.2M	↑ 1.36%
Net Income	$-24.7M	↑ 31.19%
Net Profit Margin	-35.77%	↓ 8.14%

	Q2 FY25	Q/Q Change
Revenue	$79.2M	↑ 14.49%
Net Income	$-19.6M	↓ 20.86%
Net Profit Margin	-24.73%	↑ 11.04%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$-1.9M	-

	FY20	Y/Y Change
Profit	$-1.3M	↓ 33.42%

	FY21	Y/Y Change
Profit	$15.9M	↓ 1364.14%

	FY22	Y/Y Change
Profit	$37.1M	↑ 133.75%

	FY23	Y/Y Change
Profit	$71.0M	↑ 91.58%

	FY24	Y/Y Change
Profit	$137.1M	↑ 92.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$25.0M	↑ 25.57%

	Q2 FY24	Q/Q Change
Profit	$30.2M	↑ 20.69%

	Q3 FY24	Q/Q Change
Profit	$36.9M	↑ 22.17%

	Q4 FY24	Q/Q Change
Profit	$43.7M	↑ 18.32%

	Q1 FY25	Q/Q Change
Profit	$44.2M	↑ 1.12%

	Q2 FY25	Q/Q Change
Profit	$51.7M	↑ 17.18%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-43.8M	-
Investing Cash Flow	$43.2M	-
Financing Cash Flow	$26.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$-48.3M	↑ 10.33%
Investing Cash Flow	$-233.0K	↓ 100.54%
Financing Cash Flow	$106.8M	↑ 302.5%

	FY21	Y/Y Change
Operating Cash Flow	$-57.3M	↑ 18.6%
Investing Cash Flow	$-592.0K	↑ 154.08%
Financing Cash Flow	$262.1M	↑ 145.49%

	FY22	Y/Y Change
Operating Cash Flow	$-80.4M	↑ 40.2%
Investing Cash Flow	$-2.7M	↑ 348.14%
Financing Cash Flow	$3.6M	↓ 98.62%

	FY23	Y/Y Change
Operating Cash Flow	$-108.0M	↑ 34.36%
Investing Cash Flow	$-25.2M	↑ 850.09%
Financing Cash Flow	$167.8M	↑ 4545.49%

	FY24	Y/Y Change
Operating Cash Flow	$-99.2M	↓ 8.14%
Investing Cash Flow	$-4.4M	↓ 82.51%
Financing Cash Flow	$180.1M	↑ 7.35%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-32.3M	↑ 30.22%
Investing Cash Flow	$-1.9M	↓ 77.67%
Financing Cash Flow	$2.6M	↓ 9.77%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-15.7M	↓ 51.26%
Investing Cash Flow	$-1.0M	↓ 46.4%
Financing Cash Flow	$5.3M	↑ 104.8%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-18.8M	↑ 19.47%
Investing Cash Flow	$-246.0K	↓ 76.41%
Financing Cash Flow	$1.7M	↓ 67.62%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-32.4M	↑ 72.29%
Investing Cash Flow	$-1.2M	↑ 377.24%
Financing Cash Flow	$170.5M	↑ 9843.32%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-17.0M	↓ 47.58%
Investing Cash Flow	$-1.8M	↑ 56.39%
Financing Cash Flow	$1.3M	↓ 99.24%

Procept Biorobotics Technicals Summary

Sell

Neutral

Buy

Procept Biorobotics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Procept Biorobotics Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Procept Biorobotics	-17.17%	-33.7%	-49.14%	-0.74%	-4.2%
Medtronic Plc	2.84%	-1.59%	4.76%	5.55%	-13.65%
Edwards Lifesciences Corp.	2.57%	13.95%	16.28%	-9.71%	-5.23%
Boston Scientific Corp.	0.55%	0.6%	28.99%	161.72%	157.19%
Stryker Corporation	-0.31%	-0.85%	8.63%	90.8%	97.58%
Abbott Laboratories	5.15%	-5.37%	17.14%	29.26%	21.21%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Procept Biorobotics	53.06	NA	NA	-1.49	-0.26	-0.13	NA	6.94
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Procept Biorobotics	Buy	$2.3B	-4.2%	53.06	-30.6%
Medtronic Plc	Buy	$118.0B	-13.65%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.23%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	157.19%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.58%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	21.21%	16.64	32.43%

About Procept Biorobotics

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Organization	Procept Biorobotics
Employees	756
CEO	Dr. Reza Zadno Ph.D.
Industry	Healthcare

Key Management of Procept Biorobotics

Name	Title
Dr. Reza Zadno Ph.D.	President, CEO & Director
Mr. Kevin Waters	Executive VP & CFO
Ms. Alaleh Nouri	EVP, Chief Legal Officer & Corporate Secretary
Mr. Hisham Shiblaq	Executive VP & Chief Commercial Officer
Mr. Christofer Christoforou	Senior Vice President of Operations
Mr. Barry Templin	Executive VP of Technology & Clinical Development
Mr. Matthew James Bacso C.F.A.	Vice President of Investor Relations
Ms. Stacey L. Porter	Chief People Officer
Mr. Bijesh Chandran	Senior Vice President of Regulatory Affairs & Quality Assurance

Important FAQs about investing in PRCT Stock from India :

What is Procept Biorobotics share price today?

Procept Biorobotics share price today is $40.20 as on August 30, 2025 at 1:29 am IST at the close of the market. Procept Biorobotics share today touched a day high of $40.60 and a low of $40.00.

What is the 52 week high and 52 week low for Procept Biorobotics share?

Procept Biorobotics share touched a 52 week high of $103.81 and a 52 week low of $37.12. Procept Biorobotics stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $40.20, lower by 61.28% versus the 52 week high.

How to invest in Procept Biorobotics Stock (PRCT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Procept Biorobotics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Procept Biorobotics Shares that will get you 0.0373 shares as per Procept Biorobotics share price of $40.20 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Procept Biorobotics Stock (PRCT) from India?

Indian investors can start investing in Procept Biorobotics (PRCT) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Procept Biorobotics stock (as per the Rupee-Dollar exchange rate as on August 30, 2025). Based on Procept Biorobotics share’s latest price of $40.20 as on August 30, 2025 at 1:29 am IST, you will get 0.2488 shares of Procept Biorobotics. Learn more about fractional shares .

What are the returns that Procept Biorobotics has given to Indian investors in the last 5 years?

Procept Biorobotics stock has given -4.2% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?